Horvath G, Andersson H, Mellqvist L, Leser G, Delle U
Division of Gynecological Oncology, Sahlgren's Hospital, Gothenburg, Sweden.
In Vivo. 1994 Mar-Apr;8(2):259-62.
Ten human endometrial adenocarcinoma grafts were subsequently transplanted from an original tumour growing in nude mice for several years and nine were investigated for cell proliferation, tumour volume growth, allele imbalance and protein products of Rb and p53 suppressor genes to study a possible inherited connection between these factors. We did not find faster tumour volume growth in tumours with increased cell proliferation, in contrast to melanomas and breast cancers growing in nude mice. We concluded that a probably existing link between mechanisms regulating cell proliferation and cell loss in these two tumours does not operate in endometrial carcinoma as measured by us. The tumour progression may be one important factor which influences mechanisms regulating cell proliferation and cell loss.
随后,从一只在裸鼠体内生长了数年的原发性肿瘤上取下10个人类子宫内膜腺癌移植物,并对其中9个移植物进行了细胞增殖、肿瘤体积生长、等位基因失衡以及Rb和p53抑癌基因蛋白质产物的研究,以探讨这些因素之间可能存在的遗传联系。与在裸鼠体内生长的黑色素瘤和乳腺癌不同,我们并未发现在细胞增殖增加的肿瘤中肿瘤体积生长更快。我们得出结论,就我们所测量的而言,调节这两种肿瘤细胞增殖和细胞丢失的机制之间可能存在的联系在子宫内膜癌中并不起作用。肿瘤进展可能是影响调节细胞增殖和细胞丢失机制的一个重要因素。